ClinicalTrials.govpublic full text
Evaluation of the Rimonabant Impact on the Regression of Asymptomatic Damage Caused by Cardiovascular Risk Factors
obesity, microalbuminuria, diabetes mellitus, type 2, dyslipidemia
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 172489
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.